Web Map For Collection 中文 English
Home About us Organization Principal Investigators Research Education& Training Academic activities Facilities Careers Downloads Contact us
Location:Home - News


Xian Janssen Partners with Tsinghua University to Tackle Respiratory Diseases in China




4th Annual Public Health Day Themed “Innovation and Partnership for Healthier Breathing”


BEIJING, May 29, 2014 — Today, Xian Janssen partnered with Tsinghua University to host a Public Health Day that featured academia, leading government officials and respiratory health experts who addressed the theme of “Innovation and Partnership for Healthier Breathing.” This year’s event, which focused on respiratory diseases, marks the fourth year of the Tsinghua-Janssen collaboration to fight the battle against infectious diseases in China.


Participants at today’s event included Wang Chen, Director of Department of Medical Sciences, Technology and Education, NHFPC (National Health and Family Planning Commission of People’s Republic of China); Wang Yu, Director of the Chinese Center For Disease Control And Prevention (CDC); Shi Yigong, Dean of the School of Life Sciences and Director of Institute of Biomedicine of Tsinghua University; Cesar Rodriguez, President of Xian Janssen Pharmaceutical Ltd; and Zhao Dayao, Vice President and Head of Janssen China R&D, as well as respiratory disease experts.


“The high-incidence of respiratory infections and the prevalence of chronic respiratory diseases are leading to grave public health challenges,” said Wang Chen.


There are now approximately 43 million people suffering from chronic obstructive pulmonary disease (COPD)[1] in China and approximately 20 million people who have been diagnosed with asthma[2]. Air pollution has caused nearly 300,000 to 500,000 premature deaths annually in recent years[3], and the national government has emphasized the importance of respiratory disease control. China's Chronic Disease Prevention and Control Work Plan (2012-2015), co-published by a panel of 15 government ministries, including the Ministry of Health, places chronic respiratory diseases among the nation’s most urgent priorities. [4]


“Under the guidance of the National Health and Family Planning Commission of China, CDC has rolled out initiatives to develop strategic research for the prevention and control of emerging infectious diseases, such as the establishment of 409 network laboratories and 554 sentinel surveillance hospitals for influenza research,” said Wang Yu. “We expect that collaboration from government, research institutions, universities and pharmaceutical companies will continue to play a major role in combatting infectious diseases.”


Today’s event included an announcement that an additional group of 30 physicians and scientists will participate in the Tsinghua-Janssen Joint Research Center’s research program.


“With the outstanding research and innovative capabilities of Tsinghua University, we have been glad to make a positive contribution in the fight against infectious diseases in the last few years through a productive partnership with Xian Janssen,” said Shi Yigong.


“We value platforms such as the Tsinghua-Janssen Public Health Day because they help to facilitate an exchange of ideas among the wider community,” said Cesar Rodriguez. “That leads to insights that help us fulfill our commitment to providing Chinese patients with innovative medicines that make a difference to their lives.”




For more information, please contact:




Contact person: Maggie Sun

Contact number: 8610 5821 8458

E-Mail: ysun31@ITS.JNJ.COM

Contact person: Queena Huang

Contact number: 8610 5821 1441

E-Mail: jhuang5@ITS.JNJ.COM



All right reserved Center For Life Sciences